NADPH Oxidase Inhibitors Stabilize Type XVII Collagen
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hair loss and graying are inadequate, as they do not effectively address the underlying mechanisms of hair follicle miniaturization and DNA damage accumulation in aged hair follicle stem cells.
Innovation Solution
The development of compositions that stabilize type XVII collagen expression, specifically by suppressing its degradation using inhibitors of neutrophil elastase, to promote hair growth and prevent graying.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional hair loss treatments (minoxidil, finasteride) are used, then hair growth is promoted through vasodilation and DHT inhibition, but they do not effectively address the underlying mechanism of type XVII collagen degradation and DNA damage accumulation in aged hair follicle stem cells
Solution Approach 1:
The patent extracts and targets the specific pathological mechanism of type XVII collagen degradation by neutrophil elastase in aged hair follicle stem cells, separating this key pathological factor from the complex web of aging-related changes. By focusing on this specific extracted target rather than treating all aging effects simultaneously, the invention achieves more effective and mechanism-specific treatment.
Solution Approach 2:
The patent applies preliminary protective action by stabilizing type XVII collagen expression before significant hair follicle miniaturization occurs. The composition prevents the degradation process rather than merely responding to established damage, maintaining the stem cell signature and preventing the cascade of adverse effects that follow collagen loss.
2Stability of the object's composition
If hair follicle stem cells undergo aging with DNA damage accumulation, then intrinsic genome instability increases, but type XVII collagen degradation accelerates hair follicle miniaturization and hair loss
Solution Approach 1:
The patent introduces an intermediary protective mechanism that stabilizes type XVII collagen expression despite the presence of neutrophil elastase and DNA damage. This intermediary action prevents the direct harmful effect of elastase-mediated collagen degradation, allowing the stem cell signature to be maintained even in aged cells with accumulated DNA damage.
Solution Approach 2:
The composition applies preliminary anti-action by counteracting the degradative effect of neutrophil elastase on type XVII collagen before it can cause significant hair follicle miniaturization. This preemptive stabilization prevents the harmful cascade that would otherwise lead to stem cell exhaustion and hair loss.
3Reliability
If neutrophil elastase activity increases in aged hair follicles, then type XVII collagen is degraded, but current treatments do not specifically inhibit this enzymatic degradation
Solution Approach 1:
The patent changes the therapeutic parameter from general vasodilation or DHT inhibition to specific enzymatic inhibition of neutrophil elastase. By targeting the specific biochemical parameter of elastase-mediated collagen degradation, the invention achieves more reliable hair loss suppression through mechanism-specific intervention.
Solution Approach 2:
The invention extracts the specific pathological enzyme (neutrophil elastase) from the complex aging process and targets it specifically. This extraction of the key harmful factor allows for focused therapeutic intervention that is more effective than broad-spectrum approaches.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compositions effectively suppress hair loss and graying by maintaining the stem cell signature of hair follicle stem cells, thereby delaying hair follicle miniaturization and promoting hair growth.
Implementation Method 1
NADPH oxidase is an enzyme that generates reactive oxygen species
Implementation Method 2
type XVII collagen degradation by X-ray radiation which is known to induce DNA damage
Data Source
Figure 1A~1D
Figure 1E~1F
Figure 1G~1H
AI summary
The present invention provides novel compositions for suppressing or improving hair loss, and compositions for suppressing or improving graying. More specifically, it provides agents that stabilize type XVII collagen expression, preferably agents that suppress the degradation of type XVII collagen by ELANE inhibitors and such, and compositions comprising a DNA repair-promoting agent or a DNA damage-suppressing agent as an active ingredient. Advantageous suppressive effects of hair loss and graying can be obtained when a composition comprising as an active ingredient a suppressive agent of type XVII collagen degradation such as an ELANE inhibitor is administered to a mammal. For the ELANE inhibitors, suppressive agents of type XVII collagen degradation and DNA repair-promoting agents, low-molecular compounds, polypeptides, proteins, antibodies, or nucleic acid medicine such as antisense oligos or siRNAs may be used. A method of screening for effective substances for suppression of hair loss and graying is also provided.